Technology
Novel mRNA delivery vehicle provides alternative to LNPs for SARS-CoV-2 vaccines – News-Medical.Net
Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are currently used in vaccines…
Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are currently used in vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
The lipid nanoparticle (LNP) delivery vehicles have inherent immunostimulatory properties that can induce adverse events such as allergic reactions.
Now, Ronald Levy and colleagues from Stanford University…
-
Noosa News16 hours agoProtest calls for shark net removal
-
General15 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
Noosa News18 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
Noosa News8 hours agoYork family honours late son with tractor museum to fund cancer research